You have 9 free searches left this month | for more free features.

Homozygous

Showing 1 - 25 of 665

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Nov 3, 2022

Patients With High Cholesterol and Normal Volunteers

Completed
  • Homozygous Familial Hypercholesterolemic
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 12, 2023

    Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

    Active, not recruiting
    • Homozygous Familial Hypercholesterolemia
    • IBI306
    • Beijing, China
      Beijing Anzhen Hospital, Capital Medical University
    Sep 12, 2022

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

    Active, not recruiting
    • Homozygous Familial Hypercholesterolemia
    • Wilmington, Delaware
    • +10 more
    Jan 30, 2023

    The Rogosin Institute Homozygous Familial Hypercholesterolemia

    Recruiting
    • Homozygous Familial Hypercholesterolemia
      • New York, New York
        The Rogosin Institute, Weill Cornell Medical College
      Feb 28, 2022

      Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

      Recruiting
      • Homozygous Familial Hypercholesterolemia
      • ARO-ANG 3 Injection
      • Mount Sinai, New York
      • +7 more
      Sep 26, 2022

      Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

      Not yet recruiting
      • Heterozygous or Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Dec 27, 2022

      Colorectal Polyp Trial in Zaragoza (Milk from genetically selected homozygous- ß-casein-A2 cows fed with forages and a

      Recruiting
      • Colorectal Polyp
      • Milk from genetically selected homozygous- β-casein-A2 cows fed with forages and a concentrate enriched on linseed and selenized yeast as sources of PUFAs and selenium
      • +5 more
      • Zaragoza, Spain
        Angel Lanas Arbeloa
      Sep 1, 2022

      Homozygous Familial Hypercholesterolaemia (HoFH) Trial in Worldwide (Lomitapide)

      Recruiting
      • Homozygous Familial Hypercholesterolaemia (HoFH)
      • Heidelberg, Baden-Wurttemberg, Germany
      • +13 more
      Apr 4, 2022

      Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

      Recruiting
      • Head and Neck Cancer
      • +2 more
      • Bordeaux, France
      • +2 more
      Jul 22, 2022

      Sickle Cell Disease Trial in Marseille (NUV001)

      Not yet recruiting
      • Sickle Cell Disease
      • NUV001
      • Marseille, France
        Aphm Hopital La Timone Adultes Sce Medecine Interne (Umap)
      Mar 28, 2023

      Familial Hypercholesterolemia - Homozygous, Lipid Metabolism Disorders, Proprotein Convertase Subtilisin/Kexin 9 Trial in

      Recruiting
      • Familial Hypercholesterolemia - Homozygous
      • +2 more
      • IBI306
      • Shenzhen, Guangdong, China
        xili People's Hospital
      Jun 29, 2021

      Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,

      Recruiting
      • Homozygous Familial Hypercholesterolemia
      • Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
      • Philadelphia, Pennsylvania
      • +3 more
      Sep 28, 2022

      Glucose Tolerance Abnormalities in Cystic Fibrosis Homozygous

      Completed
      • Cystic Fibrosis Homozygous for Phe 508 Del CFTR
      • Glucose Intolerance or Newly Diagnosis Diabetes
      • Lumacaftor-Ivacaftor treatment
      • Strasbourg, Alsace, France
      • +12 more
      Nov 23, 2021

      Hyperlipemia Trial in Beijing (JS002)

      Active, not recruiting
      • Hyperlipemia
      • Beijing, Beijing, China
        Beijing Anzhen Hospital Capital Medical University
      Jan 24, 2022

      Sickle Cell Disease Trial in United Kingdom, United States (IMR-687, Placebo)

      Completed
      • Sickle Cell Disease
      • Oakland, California
      • +12 more
      Mar 22, 2022

      Cystic Fibrosis Trial in Germany (LUM, LUM/IVA, IVA)

      Completed
      • Cystic Fibrosis
      • Berlin, Germany
      • +4 more
      Nov 8, 2021

      Vytorin Reexamination Study (0653A-174)

      Completed
      • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
        • (no location specified)
        Feb 7, 2022

        Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

        Active, not recruiting
        • Homozygous Familial Hypercholesterolemia
        • Evanston, Illinois
        • +11 more
        Jul 13, 2022

        Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)

        Completed
        • Solid Tumors
        • Hematological Malignancies
        • Belinostat IV
        • Santa Monica, California
        • +2 more
        Sep 10, 2021

        Orkambi Treatment in 2 to 5 Year Old Children With CF

        Completed
        • Cystic Fibrosis
        • Philadelphia, Pennsylvania
          Children's Hospital of Philadelphia
        Dec 1, 2021

        Ezetimibe onSelect Population of Filipinos With

        Completed
        • Primary Hypercholesterolemia
        • Homozygous Familial Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022